Global Calcium is one of the leading manufacturers and exporters of
Ferrous Glycine Sulphate CAS no. 14729-84-1, Mineral Actives
. We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.
As manufacturer of Ferrous Glycine Sulphate we hereby state the following facts about the drug:
Ferrous glycine sulfate is an iron supplement indicated in the treatment of iron deficiency and iron-deficiency anemia.
The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anti-carcinogenic and cognition-enhancing activities. Iron is necessary for the production of hemoglobin. Iron deficiency can lead to decreased production of hemoglobin and microcytic, hypochromic anemia.
The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen, and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
Therapeutic effectiveness and uses:
Ferrous glycine sulfate, a hematinic, is indicated for the treatment and maintenance of iron deficiency and iron-deficiency anemia. However, other causes of iron deficiency anemia such as vitamin B12 or folate deficiency anemia should be ruled out before ferrous glycine sulfate treatment
Other related information:
Ferrous glycine sulfate is contraindicated in patients with hemolytic anemia, hemochromatosis, hemosiderosis, and other iron overload disorders. Hematinic may aggravate regional enteritis, peptic ulcer, and ulcerative colitis
Ferrous glycine sulfate can cause pyrosis, chronic constipation, chest pain, injection-site reaction, anaphylactic reactions, flushing, diarrhea or constipation, regurgitation, dark-colored stools, pyrosis, temporary discoloration of teeth, and nausea
Ferrous glycine sulfate and pregnancy: USFDA pregnancy category B- Ferrous glycine sulfate may not cause harm to an unborn fetus. Before ferrous glycine sulfate treatment, the patient should discuss with the physician, if they are planning for a pregnancy
Ferrous glycine sulfate and lactation: It is not known whether ferrous glycine sulfate can pass through breast milk or not. Breastfeeding mothers should avoid nursing while taking ferrous glycine sulfate
Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market